Literature DB >> 9546005

Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm.

A Broocks1, A Thiel, D Angerstein, D Dressler.   

Abstract

OBJECTIVE: The prevalences of obsessive-compulsive symptoms in patients suffering from blepharospasm and in those with hemifacial spasm were determined. The two conditions have similar symptoms, but only blepharospasm is etiologically linked to basal ganglia dysfunction.
METHOD: After being interviewed with the Structured Clinical Interview for DSM-III-R, 13 patients with blepharospasm and 13 with hemifacial spasm completed the SCL-90-R and the Hamburg Obsession/Compulsion Inventory-Short Form.
RESULTS: Patients in the blepharospasm group had significantly more obsessive-compulsive symptoms, as indicated by higher scores on the Hamburg Obsession/Compulsion Inventory-Short Form, than the patients with hemifacial spasm. SCL-90-R scores were in the normal range for nine and eight categories, respectively (out of nine).
CONCLUSIONS: The findings provide additional support for the hypothesis that obsessive-compulsive symptoms are related to basal ganglia dysfunction.

Entities:  

Mesh:

Year:  1998        PMID: 9546005     DOI: 10.1176/ajp.155.4.555

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  15 in total

1.  Altered regional spontaneous neuronal activity in blepharospasm: a resting state fMRI study.

Authors:  Jing Yang; ChunYan Luo; Wei Song; Qin Chen; Ke Chen; XuePing Chen; XiaoQi Huang; QiYong Gong; HuiFang Shang
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 4.849

2.  Residual hemifacial spasm after microvascular decompression: prognostic factors with emphasis on preoperative psychological state.

Authors:  Yichao Jin; Changyi Zhao; Shanshan Su; Xiaohua Zhang; Yongming Qiu; Jiyao Jiang
Journal:  Neurosurg Rev       Date:  2015-04-15       Impact factor: 3.042

Review 3.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

Review 4.  Nonmotor manifestations of dystonia: a systematic review.

Authors:  Daniel J Kuyper; Veronica Parra; Shanae Aerts; Michael S Okun; Benzi M Kluger
Journal:  Mov Disord       Date:  2011-04-11       Impact factor: 10.338

5.  Obsessive-compulsive disorder is not a clinical manifestation of the DYT1 dystonia gene.

Authors:  Gary A Heiman; Ruth Ottman; Rachel J Saunders-Pullman; Laurie J Ozelius; Neil J Risch; Susan B Bressman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-04-05       Impact factor: 3.568

6.  Psychiatric disorders in idiopathic-isolated focal dystonia.

Authors:  Alexander Lehn; George Mellick; Richard Boyle
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

7.  Depression in focal, segmental and generalized dystonia.

Authors:  L Lewis; A Butler; M Jahanshahi
Journal:  J Neurol       Date:  2008-11-13       Impact factor: 4.849

Review 8.  The non-motor syndrome of primary dystonia: clinical and pathophysiological implications.

Authors:  Maria Stamelou; Mark J Edwards; Mark Hallett; Kailash P Bhatia
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

9.  SGCE mutations cause psychiatric disorders: clinical and genetic characterization.

Authors:  Kathryn J Peall; Daniel J Smith; Manju A Kurian; Mark Wardle; Adrian J Waite; Tammy Hedderly; Jean-Pierre Lin; Martin Smith; Alan Whone; Hardev Pall; Cathy White; Andrew Lux; Philip Jardine; Narinder Bajaj; Bryan Lynch; George Kirov; Sean O'Riordan; Michael Samuel; Timothy Lynch; Mary D King; Patrick F Chinnery; Thomas T Warner; Derek J Blake; Michael J Owen; Huw R Morris
Journal:  Brain       Date:  2013-01       Impact factor: 13.501

10.  Prefrontal Hemodynamic Functions during a Verbal Fluency Task in Blepharospasm Using Multi-Channel NIRS.

Authors:  Chen-Yu Shen; Yong-Jun Wang; Xiao-Qian Zhang; Xiao-Min Liu; Xia-Jin Ren; Xiang-Yun Ma; Jing-Jing Sun; Kun Feng; Gao-Xiang Sun; Bo Xu; Po-Zi Liu
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.